Calandra, Thierry

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 4,917

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 3,191

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases

Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility

Cited by 1,964

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityOcular Infections and Treatments

Cited by 1,217

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 887

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

Tissot, F., Agrawal, S., Pagano, L., Petrikkos, G., Groll, A. H., Skiada, A., Lass-Flörl, C., Calandra, T., Viscoli, C., & Herbrecht, R. (2017) · Haematologica

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 682

Changes in the epidemiological landscape of invasive candidiasis

Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 547

Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000

Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 478

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients

Eggimann, P., Francioli, P., Bille, J., Schneider, R., Wu, M.-M., Chapuis, G., Chiolero, R., Pannatier, A., Schilling, J., Geroulanos, S., et al. (1999) · Critical Care Medicine

Antifungal resistance and susceptibilitySurgical site infection prevention

Cited by 414

ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

Cuenca-Estrella, M., Verweij, P. E., Arendrup, M. C., Arikan-Akdagli, S., Bille, J., Donnelly, J. P., Jensen, H. E., Lass-Flörl, C., Richardson, M. D., Akova, M., et al. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 386

Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection

Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A.-L., Reymond, M. K., Miconnet, I., et al. (2011) · Blood

Histone Deacetylase Inhibitors ResearchImmune Response and Inflammation

Cited by 341

ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 334

The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: Recommendations from the Third European Conference on Infections in Leukemia

Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 319

Bench-to-bedside review: Candida infections in the intensive care unit

Méan, M., Marchetti, O., & Calandra, T. (2008) · Critical Care

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 217

Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1

Roger, T., Chanson, A., Knaup‐Reymond, M., & Calandra, T. (2005) · European Journal of Immunology

Macrophage Migration Inhibitory FactorImmune cells in cancer

Cited by 184

Antibiotics for sepsis-finding the equilibrium.

Klompas, M., Calandra, T., & Singer, M. (2018) · JAMA

Sepsis Diagnosis and TreatmentAntibiotics Pharmacokinetics and Efficacy

Cited by 183

Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice

Prescott, H. C., Iwashyna, T. J., Blackwood, B., Calandra, T., Chlan, L. L., Choong, K., Connolly, B., Dark, P., Ferrucci, L., Finfer, S., et al. (2019) · American Journal of Respiratory and Critical Care Medicine

Sepsis Diagnosis and TreatmentIntensive Care Unit Cognitive Disorders

Cited by 166

Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases

Rello, J., van Engelen, T. S. R., Alp, E., Calandra, T., Cattoir, V., Kern, W. V., Netea, M. G., Nseir, S., Opal, S. M., van de Veerdonk, F. L., et al. (2018) · Clinical Microbiology and Infection

Sepsis Diagnosis and TreatmentBacterial Identification and Susceptibility Testing

Cited by 143

Histone Deacetylase Inhibitors Impair Antibacterial Defenses of Macrophages

Mombelli, M., Lugrin, J., Rubino, I., Chanson, A.-L., Giddey, M., Calandra, T., & Roger, T. (2011) · The Journal of Infectious Diseases

Histone Deacetylase Inhibitors ResearchNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 89

Implementing Artificial Intelligence in Critical Care Medicine: a consensus of 22.

Cecconi, M., Greco, M., Shickel, B., Angus, D. C., Bailey, H., Bignami, E., Calandra, T., Celi, L. A., Einav, S., Elbers, P., et al. (2025) · Critical Care

Artificial Intelligence in Healthcare and EducationMachine Learning in Healthcare

Cited by 80

Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey

Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., et al. (2021) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 37